Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
J Mater Chem B ; 8(36): 8282-8293, 2020 09 23.
Artigo em Inglês | MEDLINE | ID: mdl-32785356

RESUMO

Hemorrhage remains one of the direct causes of high mortality. The development of ideal hemostatic materials with sound ability to deal with severe wound is urgent needed. Although starch-based hemostatic powder has been widely used, hydrous physiological environments severely hamper its binding to the target tissue, thereby limiting the effectiveness in hemostasis. Herein, inspired by mussel adhesive protein, a novel injectable tissue-adhesive hydrogel (St-Dopa hydrogel) composed of starch, succinic anhydride and dopamine was developed in situ by enzymatic crosslinking. The results show that St-Dopa hydrogels were intimately integrated with biological tissue and formed robust barriers to reduce blood loss. St-Dopa hydrogels exhibited superior capacity for in vitro and in vivo hemostasis as compared with chitin hydrogels. In addition to the ease of operation, St-Dopa hydrogels exhibited rapid sol-gel transition, porous microscopic morphology, good swelling ratio and biodegradability, tissue-like elastomeric mechanical properties and excellent cyto/hemo-compatibility. These results suggest that this newly developed St-Dopa hydrogel is a promising biological adhesive and hemostatic material.


Assuntos
Hemorragia/tratamento farmacológico , Hemostasia/efeitos dos fármacos , Hemostáticos/uso terapêutico , Hidrogéis/uso terapêutico , Amido/uso terapêutico , Adesivos Teciduais/uso terapêutico , Animais , Linhagem Celular , Dopamina/análogos & derivados , Dopamina/uso terapêutico , Dopamina/toxicidade , Módulo de Elasticidade , Hemostáticos/síntese química , Hemostáticos/toxicidade , Hidrogéis/síntese química , Hidrogéis/toxicidade , Masculino , Teste de Materiais , Camundongos , Porosidade , Coelhos , Amido/análogos & derivados , Amido/toxicidade , Anidridos Succínicos/química , Anidridos Succínicos/uso terapêutico , Anidridos Succínicos/toxicidade , Suínos , Adesivos Teciduais/síntese química , Adesivos Teciduais/toxicidade , Substâncias Viscoelásticas/síntese química , Substâncias Viscoelásticas/uso terapêutico , Substâncias Viscoelásticas/toxicidade
2.
Nutr Cancer ; 68(6): 1052-63, 2016.
Artigo em Inglês | MEDLINE | ID: mdl-27367460

RESUMO

Dietary fiber has been reported to prevent preneoplastic colon lesions. The aim of this study was to determine the effect of resistant starches, novel dietary fibers, on the development of colonic preneoplasia and Wnt signaling in azoxymethane (AOM)-treated rats and mice fed resistant starches at 55% of the diet after AOM treatment. Another objective was to determine the effect of resistant starches on the development of preneoplasia in rats treated with antibiotics (Ab), administered between AOM treatment and resistant starch feeding. Diets containing resistant starches, high-amylose (HA7), high-amylose-octenyl succinic anhydride (OS-HA7), or high-amylose-stearic acid (SA-HA7) were compared with control cornstarch (CS). The resistant starch content of the diets did not alter the yield of colonic lesions but animals treated with AOM and fed the diet with the highest resistant starch content, SA-HA7 developed the highest average aberrant crypt foci (ACF) per animal. Mice fed the OS-HA7 diet had decreased expression of some upstream Wnt genes in the colonic crypts. This study suggests that further research is needed to determine if resistant starch impacts colon carcinogenesis in rodents.


Assuntos
Anticarcinógenos/uso terapêutico , Neoplasias do Colo/prevenção & controle , Prebióticos , Lesões Pré-Cancerosas/prevenção & controle , Amido/uso terapêutico , Via de Sinalização Wnt , Focos de Criptas Aberrantes/metabolismo , Focos de Criptas Aberrantes/microbiologia , Focos de Criptas Aberrantes/patologia , Focos de Criptas Aberrantes/prevenção & controle , Animais , Antibacterianos/efeitos adversos , Anticarcinógenos/metabolismo , Azoximetano/toxicidade , Carcinógenos/toxicidade , Colo/efeitos dos fármacos , Colo/metabolismo , Colo/microbiologia , Neoplasias do Colo/metabolismo , Neoplasias do Colo/microbiologia , Neoplasias do Colo/patologia , Microbioma Gastrointestinal/efeitos dos fármacos , Regulação Neoplásica da Expressão Gênica/efeitos dos fármacos , Mucosa Intestinal/efeitos dos fármacos , Mucosa Intestinal/metabolismo , Mucosa Intestinal/microbiologia , Camundongos Endogâmicos A , Proteínas de Neoplasias/genética , Proteínas de Neoplasias/metabolismo , Lesões Pré-Cancerosas/metabolismo , Lesões Pré-Cancerosas/microbiologia , Lesões Pré-Cancerosas/patologia , Ratos Endogâmicos F344 , Amido Resistente , Amido/análogos & derivados , Amido/metabolismo , Ácidos Esteáricos/metabolismo , Ácidos Esteáricos/uso terapêutico , Anidridos Succínicos/metabolismo , Anidridos Succínicos/uso terapêutico , Carga Tumoral/efeitos dos fármacos , Via de Sinalização Wnt/efeitos dos fármacos
3.
Farmakol Toksikol ; 52(5): 41-3, 1989.
Artigo em Russo | MEDLINE | ID: mdl-2599076

RESUMO

Pirrolidone-2, gamma-butyrolacton, succinic anhydride were found to possess pronounced antihypoxic activity that manifested itself in their ability to decrease the level of lactic acid accumulated during hypoxia. Pirrolidone-2 and succinic anhydride increase succinic dehydrogenase activity in vitro. At intraperitoneal administration the above mentioned compounds lead to lactate dehydrogenase activity inhibition under normal conditions while during circulatory hypoxia they stimulate lactate dehydrogenase reaction promoting the maintenance of energy balance of the cerebral tissue at the appropriate level.


Assuntos
Hipóxia Encefálica/tratamento farmacológico , Ácido gama-Aminobutírico/análogos & derivados , 4-Butirolactona/uso terapêutico , Animais , Encéfalo/efeitos dos fármacos , Encéfalo/metabolismo , Avaliação Pré-Clínica de Medicamentos , Hipóxia Encefálica/metabolismo , L-Lactato Desidrogenase/metabolismo , Lactatos/metabolismo , Ácido Láctico , Pirrolidinonas/uso terapêutico , Piruvatos/metabolismo , Ácido Pirúvico , Ratos , Succinato Desidrogenase/metabolismo , Anidridos Succínicos/uso terapêutico , Ácido gama-Aminobutírico/uso terapêutico
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...